Chinese
Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Overview of attention for article published in Multiple Sclerosis Journal, September 2017
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
High Attention Score compared to outputs of the same age and source (93rd percentile)
Mentioned by
- news
- 4 news outlets
- blogs
- 2 blogs
- policy
- 1 policy source
- 20 X users
- patent
- 5 patents
- wikipedia
- 6 Wikipedia pages
- 1 Redditor
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 299 Mendeley